Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
Jean Connors, Chief of Cancer Hematology at Dana-Farber Cancer Institute, shared Journal of Thrombosis and Haemostasis‘s post on LinkedIn:
“Truly wonderful to work with the dedicated team of Brigham and Women’s Hospital pharmacists Elizabeth Caudill, Ju Hee Kim, Dareen Kanaan, Katelyn Sylvester, Liriany Pimentel Rodriguez, Christine Kim as part our Hemostatic Antithrombotic Stewardship program, to address this important question: can patients with remote HIT be re-exposed to UFH?”
Journal of Thrombosis and Haemostasis shared a post on LinkedIn about a recent article by Elizabeth B. Caudill et al, adding:
“Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
This single-center retrospective study followed 35 patients with prior heparin-induced thrombocytopenia who were re-exposed to heparin products. Only one (2.9 percent) developed recurrent HIT, with no associated thrombosis, bleeding, or in-hospital mortality. Median interval from HIT diagnosis to re-exposure was 8.1 years, suggesting re-exposure may be safe in remote HIT.”
Title: Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
Authors: Elizabeth B. Caudill, Ju Hee Kim, Dareen M. Kanaan, Katelyn W. Sylvester, Liriany Y. Pimentel, Christine S. Kim, Jean M. Connors
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?